Skip to content
Home/Companies/Biotech/Nitrase Therapeutics
NT

Nitrase Therapeutics

Biotech·US·Active·6yr hold

Nitrase Therapeutics is a healthcare / biotech company, headquartered in United States.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Nitrase Therapeutics?

Nitrase Therapeutics is currently owned by Sofinnova Partners through Sofinnova Capital IX (2018 vintage), since 2020.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital IX · 2018 · Life Sciences VC

Key facts

HQUnited States
SectorHealthcare / Biotech

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

Asceneuron
Active
BiotechSwitzerland· 2020
CorVent Medical
Active
MedTechUS· 2020
Genespire
Active
BiotechItaly· 2020
Noema Pharma
Exited 2022
BiotechSwitzerland· 2020
to
Pi-Cardia
Active
MedTechIsrael· 2020
Pyrowave
Active
BiotechCanada· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings